作者: An Truong , Emily Si , Thomas Duncan , Michael Valenzuela
DOI: 10.1007/S11515-016-1413-3
关键词: Neuroscience 、 Disease 、 Somatic cell 、 Reprogramming 、 Phenotype 、 Neurodegeneration 、 Proteomics 、 Biology 、 Stem cell 、 Amyotrophic lateral sclerosis
摘要: Development of new therapeutic targets for neurodegenerative disorders has been hampered by a reliance on post mortem tissue that is representative end-stage disease, or animal models fail to provide faithful analogs. However, rapid advances in cellular genetic reprogramming, particular the induction somatic cells into stem cells, directly neurons, led intense interest modeling human neurodegeneration vitro. Here, we critically review current methods and recent progress Alzheimer’s Parkinson’s disease amyotrophic lateral sclerosis. Several challenges are identified, including technical variability, lack degenerative phenotypes, neurodevelopmental age establishing ground truths sporadic disease. Recommendations evaluating proposed along with suggestions future research.